Navigation Links
JCI table of contents: Oct. 19, 2009
Date:10/19/2009

EDITOR'S PICK: The protein APC slows Lou Gehrig's disease in mice

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that causes progressive weakness, disability, and death. Treatments are largely palliative. Using mice carrying the mutated form of the human SOD1 gene that causes inherited forms of ALS, however, Berislav Zlokovic and colleagues, at the University of Rochester Medical Center, Rochester, have now found that administration of the protein APC slows disease progression and extends survival. The authors therefore suggest that strategies designed to activate APC might be of benefit to patients with inherited, and possibly sporadic, ALS. However, in an accompanying commentary, Charles Esmon and Jonathan Glass warn that such an approach would not be without risks.

In the study, administration of both APC, whose main function is to prevent blood clotting, and APC analogs with a reduced ability to prevent blood clotting slowed disease progression in the mutant SOD1expressing mice and extended their survival, even when the compounds were administered after disease onset. Further analysis indicated that these compounds were able to access the brain and that once there, they worked by decreasing expression of the mutant SOD1 in several cell types in the brain, including the nerve cells destroyed in individuals with ALS. This study therefore indicates that APC can have a neuroprotective effect in mouse models of inherited ALS.

TITLE: Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

AUTHOR CONTACT:
Berislav V. Zlokovic
University of Rochester Medical Center, Rochester, New York, USA.
Phone: (585) 273-3132; Fax: (585) 273-3133; E-mail: berislav_zlokovic@urmc.rochester.edu.

View this article at: http://www.jci.org/articles/view/38476?key=6a5479a67edd727312aa

ACCOMPANYING COMMENTARY
TITLE: The APCs of neuroprotection

AUTHOR CONTACT:
Charles T. Esmon
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Phone: (405) 271-6474; Fax: (405) 271-2872; E-mail: Charles-Esmon@omrf.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=40682


VASCULAR BIOLOGY: Too much of the protein building block homocysteine inhibits blood vessel formation

TITLE: Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2dependent fibrinolysis

AUTHOR CONTACT:
Katherine A. Hajjar
Weill Cornell Medical College, New York, New York, USA.
Phone: (212) 746-2034; Fax: (212) 746-8809; E-mail: khajjar@med.cornell.edu.

View this article at: http://www.jci.org/articles/view/39591?key=5eb08d461852e7429305

ACCOMPANYING COMMENTARY
TITLE: Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology

AUTHOR CONTACT:
Joseph Loscalzo
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Phone: (617) 732-6340; Fax: (617) 732-6439; E-mail: jloscalzo@partners.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=40924


ONCOLOGY: Loss of the protein Smad4 associated with head and neck cancer

TITLE: Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation

AUTHOR CONTACT:
Shi-Long Lu
University of Colorado Denver, Aurora, Colorado, USA.
Phone: (303) 724-0784; Fax: (303) 724-4553; E-mail: shi-long.lu@ucdenver.edu.

Xiao-Jing Wang
University of Colorado Denver, Aurora, Colorado, USA.
Phone: (303) 724-3001; Fax: (303) 724-4730; E-mail: xj.wang@ucdenver.edu.

View this article at: http://www.jci.org/articles/view/38854?key=fc4a2214d5fa7fb45183

ACCOMPANYING COMMENTARY
TITLE: Smad4: gatekeeper gene in head and neck squamous cell carcinoma

AUTHOR CONTACT:
Murray Korc
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Phone: (603) 650-7936; Fax: (603) 650-6122; E-mail: murray.korc@dartmouth.edu.

View the PDF of this article at: https://www.the-jci.org/article.php?id=41230


NEPHROLOGY: ARH: another link in the molecular chain regulating potassium levels

TITLE: The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney

AUTHOR CONTACT:
Paul A. Welling
University of Maryland School of Medicine, Baltimore, Maryland, USA.
Phone: (410) 706-3851; Fax: (410) 706-8341; E-mail: pwelling@umaryland.edu.

View this article at: http://www.jci.org/articles/view/37950?key=eba726374c485034e543


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. Detecting the undetectable in prostate cancer screening
2. Drugs for Irritable Bowel Might Increase Cancer Risk
3. Not Getting Enough Fruits and Vegetables? Think Frozen! Antioxidant-rich Frozen Wild Blueberries are Convenient and Just As Nutritious As Fresh
4. Fabled vegetable lamb plant contains potential treatment for osteoporosis
5. Over 800 Lives of Domestic Violence Survivors Restored by the American Academy of Cosmetic Dentistry Charitable Foundations Give Back A Smile Program
6. Discrete Reportable Transcription to Populate the EHR/EMR With Physician Dictated Reports
7. Certain Types of Infertility Are Preventable
8. Long-Term Back Pain Not Inevitable, Study Finds
9. New Book Provides Alcoholics with Hope for Stable, Long-Term, Craving-Free Sobriety
10. OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover
11. A New Jersey Anti-Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson, NJ Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: